IPSC EPS Estimates
Century Therapeutics, Inc.
$1.36
-$0.02(-1.45%)
36
Overall
60
Value
18
Tech
31
Quality
Market Cap
$249.88M
Volume
6.28K
52W Range
$0.44 - $3.04
Target Price
$5.12
IPSC EPS estimates: the consensus estimate for Century Therapeutics, Inc.'s current fiscal year is -$0.51 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IPSC EPS Estimates
- EPS estimate, current quarter
- $-0.12
- EPS estimate, next quarter
- $-0.13
- EPS estimate, current year
- $-0.51
- EPS estimate, next year
- $-0.51
- EPS growth, 3-year
- +60.49%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.14 |
| 2024 | $-1.61 |
| 2023 | $-2.30 |
| 2022 | $-2.27 |
| 2021 | $-2.96 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IPSC | $1.36 | -1.4% | 6.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Century Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW